nderstanding the Molecular Mechanism of Phloridzin 3C on Oxidative Stress Induced Diabetes Mellitus through Pre-Clinical and Clinical Studies

DR KUMARAVEL V0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年5月27日

试验速览

暂无简介。

•The patient having high risk for diabetes as per Indian diabetes risk score (IDRS >60) with or without Diagnosed case of Diabetes mellitus type-II (ICD-10:E11.9-Type-2 Diabetes Mellitus without complication) as per WHO diagnostic criteria and symptomatic (polyuria, polydipsia and polyphagia) with
•i.Age: 19-65Yrs
•ii.Both Sexes
•iii.Fasting blood glucose level (FBS) > 126mg/dl or
•Postprandial blood Glucose (PPBS) > 200mg/dl or
•Glycated Haemoglobin (HbA1C ) > 6.5 % or
•Random blood glucose level (RBS) > 200mg/dl
•iv.Providing written informed consent to participate

•i.Pregnant women, Lactating women & paediatric age group ( < 18yrs)
•ii.Person under corticosteroid therapy or substance abuse
•iii.Diagnosed case of type I diabetes mellitus or diabetic ketoacidosis with in past 6 mts
•iv.Uncontrolled hypertension or >2 episodes of sever hypoglycaemia within past 6 mts
•v. Patient suffering from Diabetes mellitus type-II with complication like retinopathy, nephropathy, neuropathy and other severe infectious diseases.
•vi.Patients who are too sick for consultation and not willing to cooperate
•vii.Unwilling to take part and not giving consent to join the study

发起方

DR KUMARAVEL V